Market News (Page 34) - TendieTensor

Market News Page 34 of 277 • 6,918 articles

INSP SHAREHOLDER UPDATE: Inspire Medical Systems, Inc. Hit with Securities Class Action after 32% Stock Drop – Contact BFA Law if You Lost Money

GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp

INSP SHAREHOLDER UPDATE: Inspire Medical Systems, Inc. Hit with Securities Class Action after 32% Stock Drop – Contact BFA Law if You Lost Money

12/31/2025 08:48 AM • Inspire Medical Systems faces a securities class action lawsuit alleging fraud related to the Inspire V device launch. The company failed to adequately prepare clinicians and payors for the rollout, resulting in significant delays and weak demand. On August 4, 2025, Inspire disclosed the elongated launch timeline and reduced 2025 earnings guidance by over 80%, causing the stock to plummet 32% from $129.95 to $87.91 per share.

INSP - Company faces securities fraud allegations, failed to properly prepare for product launch, disclosed significant delays and weak demand, reduced earnings guidance by over 80%, and experienced a 32% stock price decline in a single day.

#securities fraud #class action lawsuit #Inspire V launch #stock drop #earnings guidance reduction #sleep apnea device #FDA approval

Amazon: What Could Matter Most in the 4 Weeks Ahead of Earnings

Investing.com • Sam Quirke

Amazon: What Could Matter Most in the 4 Weeks Ahead of Earnings

12/31/2025 08:46 AM • Amazon stock is trading flat year-over-year despite the S&P 500's 17% gain, but has rallied 40% since April and consistently beaten quarterly expectations. The stock has been range-bound since July with support holding after a failed November breakout. Analysts remain bullish heading into late January/early February earnings, citing strong AWS growth prospects and improving AI narrative. The technical setup suggests upside potential as the stock consolidates ahead of earnings.

AMZN - Stock has rallied 40% since April, consistently beats quarterly expectations, maintains support despite failed November breakout, majority analyst Buy ratings, improving AWS growth narrative, and favorable risk-reward setup ahead of earnings with expectations not stretched and stock not overbought.

#Amazon earnings #stock consolidation #AWS growth #AI narrative #technical analysis #analyst ratings #range-bound trading

Alibaba Backs OpenAI's Chinese Rival MiniMax In New IPO

Benzinga • Anusuya Lahiri

Alibaba Backs OpenAI's Chinese Rival MiniMax In New IPO

12/31/2025 08:42 AM • Chinese AI startup MiniMax is preparing for a Hong Kong IPO in January 2026, targeting to raise at least $492 million with a valuation of approximately $6.5 billion. Alibaba and Abu Dhabi Investment Authority are anchoring the deal as cornerstone investors. MiniMax positions itself as a rival to OpenAI and will compete with other domestic AI contenders like Zhipu AI.

BABA - Alibaba is anchoring MiniMax's IPO as a cornerstone investor with approximately $350 million commitment, demonstrating confidence in the AI startup and strategic investment in the growing Chinese AI sector.

#IPO #artificial intelligence #Hong Kong #MiniMax #Chinese AI startup #cornerstone investors #AI model development

This Technology Stock Could Turn $1,000 Into $10,000

The Motley Fool • Manali Pradhan, Cfa

This Technology Stock Could Turn $1,000 Into $10,000

12/31/2025 08:33 AM • Nebius, an AI infrastructure company providing GPU cloud services, has surged 207% in 2025 and could potentially become a 10-bagger by 2031. The company benefits from AI infrastructure capacity shortages, has secured major contracts with Meta ($3B) and Microsoft ($17.4B), and plans to expand data center capacity to 2.5 gigawatts by end of 2026. Analysts project revenues growing from $555.9M in 2025 to $27.1B in 2031.

NBIS - Strong execution with 355% YoY revenue growth in Q3, exceptional demand visibility through major contracts with Meta and Microsoft, aggressive capacity expansion plans, and analyst projections showing 48x revenue growth by 2031. Stock has already surged 207% in 2025 with potential for further gains.

#AI infrastructure #GPU cloud services #data center expansion #AI capacity shortage #revenue growth #enterprise contracts

The Quantum Shield: Hardening AI & Critical Infrastructure

GlobeNewswire Inc. • Usa News Group

The Quantum Shield: Hardening AI & Critical Infrastructure

12/31/2025 07:46 AM • The post-quantum cryptography market is projected to grow from $1.35 billion in 2025 to $22.68 billion by 2033 at a 42.33% CAGR, driven by quantum computing threats to critical infrastructure. Major cybersecurity companies are launching quantum-safe solutions and AI-driven security platforms to help enterprises migrate from legacy encryption to quantum-resilient architectures.

NVDA - Significant price drop of 3.58% and highlighted in market movers section
ACN - Announced partnership with U.S. Department of Energy for Genesis Mission to advance AI leadership and national security, positioning the company as a key contributor to federal AI infrastructure initiatives.

#post-quantum cryptography #quantum computing threats #cybersecurity #critical infrastructure #quantum-safe encryption #AI-driven security #enterprise security

Jeffs’ Brands: Fort Technology Inc. Announces Intention to List its Common Shares on the Nasdaq Capital Market

GlobeNewswire Inc. • Jeffs' Brands Ltd

Jeffs’ Brands: Fort Technology Inc. Announces Intention to List its Common Shares on the Nasdaq Capital Market

12/31/2025 07:45 AM • Jeffs' Brands announced that its majority-owned subsidiary Fort Technology Inc. plans to pursue an uplisting of its common shares from the TSX Venture Exchange to the Nasdaq Capital Market. The company believes the listing will enhance visibility, increase liquidity, and provide access to a broader investor base. Fort's management will engage advisors and prepare SEC filings to satisfy Nasdaq's listing requirements, though completion is not assured.

TSLA - Substantial price decline of 6.64% and noted in market movers
JFBR - The company is executing a strategic pivot into the growing homeland security sector and facilitating a subsidiary uplisting to a major exchange, which signals confidence in growth prospects and provides access to larger capital markets and investor bases.

#uplisting #Nasdaq Capital Market #Fort Technology Inc. #liquidity #institutional investors #homeland security #e-commerce

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

GlobeNewswire Inc. • Na

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

12/31/2025 07:00 AM • BioAtla and GATC Health announced a $40 million special purpose vehicle transaction to advance ozuriftamab vedotin (Oz-V) into a Phase 3 registrational trial for 2L+ oropharyngeal squamous cell carcinoma. BioAtla will receive an initial $5 million with the remaining $35 million expected in Q1 2026, retaining 65% ownership of Oz-V while Inversagen AI, LLC receives 35%. The Phase 3 trial is anticipated to begin enrollment in early 2026 with potential for accelerated approval.

BCAB - BioAtla secured $40 million in funding to advance its lead candidate Oz-V into Phase 3 development with a clear regulatory pathway for potential accelerated approval. The company retains 65% ownership, maintains control of trial execution, and is exploring expansion into additional HPV-positive cancer indications, representing significant value creation and de-risking of development.

#ozuriftamab vedotin #Phase 3 trial #oropharyngeal squamous cell carcinoma #special purpose vehicle #ROR2 targeting #accelerated approval #senolytic therapy #HPV-positive cancers

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

GlobeNewswire Inc. • Na

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

12/31/2025 07:00 AM • Axsome Therapeutics announced that the FDA has accepted and granted Priority Review designation to its supplemental NDA for AXS-05 for treating Alzheimer's disease agitation, with a PDUFA target action date of April 30, 2026. The drug addresses a significant unmet medical need, as up to 76% of Alzheimer's patients experience agitation. AXS-05 previously received Breakthrough Therapy designation in June 2020.

MERpK - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
AXSM - The company received FDA Priority Review designation for AXS-05, which accelerates the review timeline from 10 to 6 months. This represents significant regulatory progress for a drug addressing a major unmet medical need affecting 76% of Alzheimer's patients. The Priority Review status indicates FDA recognition of the drug's potential to provide substantial improvements over existing treatments.

#FDA approval #Priority Review #AXS-05 #Alzheimer's disease agitation #supplemental NDA #PDUFA #Breakthrough Therapy designation #dextromethorphan #bupropion

Nutriband CEO Publishes Letter to Shareholders

GlobeNewswire Inc. • Gareth Sheridan, Ceo

Nutriband CEO Publishes Letter to Shareholders

12/31/2025 07:00 AM • Nutriband Inc. reported significant progress in 2025 including the sale of 90% of its Pocono subsidiary to EarthVision Bio for $5M with no shareholder dilution, a 25% preferred stock dividend, and major advances in its lead product AVERSA Fentanyl abuse-deterrent patch. The company received FDA Type C Meeting approval, completed manufacturing scale-up, secured additional patents, and was added to four Russell indexes. The CEO highlighted shareholder value focus and anticipated warrant expiration in October 2026 as a potential positive catalyst.

BMLpL - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
NTRB - Company demonstrated strong progress toward commercialization of lead product AVERSA Fentanyl with FDA Type C Meeting approval, patent issuances, manufacturing scale-up completion, and strategic capital management through subsidiary sale without shareholder dilution. Addition to Russell indexes and preferred stock dividend also indicate positive momentum.

#abuse-deterrent fentanyl patch #AVERSA technology #FDA approval pathway #patent protection #shareholder value #commercialization #transdermal pharmaceutical #warrant expiration

Down But Not Out: 5 AI Laggards From 2025 That Could Explode In 2026

Benzinga • Vishaal Sanjay

Down But Not Out: 5 AI Laggards From 2025 That Could Explode In 2026

12/31/2025 06:31 AM • Five stocks that underperformed in 2025 are positioned for strong growth in 2026. Apple, Adobe, Palo Alto Networks, Airbnb, and Target have lagged behind their peers but analysts expect them to lead in the new year due to AI initiatives, new product launches, supply chain improvements, and attractive valuations.

AAPL - Trailed Mag 7 peers in 2025 with 12.12% YTD gains, but analyst Gene Munster predicts it will be the best performing Mag 7 stock in H1 2026 due to expected iPhone sales beat and new Siri launch before April 30.

#AI stocks #underperformers #2026 outlook #tech stocks #analyst ratings #valuation #cybersecurity #AI integration

Form 8.3 - [IQE PLC - 30 12 2025] - (CGAML)

GlobeNewswire Inc. • Na

Form 8.3 - [IQE PLC - 30 12 2025] - (CGAML)

12/31/2025 05:59 AM • Canaccord Genuity Asset Management Limited disclosed a 2.38% stake in IQE PLC as of December 30, 2025, holding 23.28 million ordinary shares. The disclosure also noted a sale of 325,000 shares at 5.009p per share, indicating a reduction in the position.

BMLpH - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
IQEPY - The disclosure is a regulatory filing showing a significant shareholding position (2.38%) by an asset manager. While the sale of shares could suggest reduced confidence, the large remaining position and routine nature of the disclosure indicate neutral sentiment. No material news or commentary suggests positive or negative outlook.

#Form 8.3 #Takeover Code #position disclosure #relevant securities #share sale #discretionary clients

GlobeNewswire Inc. • Na

Form 8.3 - Empiric Student Property Plc

12/31/2025 05:49 AM • Rathbones Group Plc has disclosed a 2.77% interest in Empiric Student Property Plc, comprising 18,435,532 ordinary shares. The disclosure was made under Rule 8.3 of the Takeover Code as of December 30, 2025. Rathbones also sold 6,000 shares at 77.52p per share during the disclosure period.

BMLpJ - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
EPRCY - The disclosure of a 2.77% stake by a major asset manager is a factual regulatory event. Without additional context regarding the nature of the stake acquisition or market implications, this represents neutral information.

#Takeover Code #Rule 8.3 #stake disclosure #relevant securities #share dealing #opening position disclosure

GlobeNewswire Inc. • Na

Form 8.5 (EPT/RI) - Greencore Group Plc

12/31/2025 04:53 AM • Shore Capital Stockbrokers Ltd, an exempt principal trader, disclosed dealings in Greencore Group Plc ordinary shares on 30 December 2025. The firm purchased 3,000 shares at 251p and sold 3,000 shares at prices ranging from 251.25p to 256p. No derivatives, options, or special arrangements were involved in the transactions.

BMLpG - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
GNCGY - This is a regulatory disclosure of routine trading activity by an intermediary acting in a client-serving capacity. The balanced purchase and sale of equal quantities (3,000 shares each) at similar price points indicates normal market-making activity with no material implications for the company's fundamentals or strategic position.

#Shore Capital Stockbrokers Ltd #Greencore Group Plc #dealing disclosure #Rule 8.5 #Takeover Code #ordinary shares #exempt principal trader

Share Buyback Transaction Details December 18 – December 30, 2025

GlobeNewswire Inc. • Na

Share Buyback Transaction Details December 18 – December 30, 2025

12/31/2025 04:00 AM • Wolters Kluwer repurchased 264,510 ordinary shares between December 18-30, 2025, for €23.7 million at an average price of €89.54 per share. This is part of a €200 million buyback program announced in November 2025, with cumulative 2025 repurchases reaching 8.56 million shares for €1.1 billion. The repurchased shares will be held as treasury shares for future capital reduction through share cancellation.

BACpQ - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
WTKWY - The company is executing a substantial €200 million share buyback program, which typically signals management confidence in the company's valuation and financial health. Buyback programs are generally viewed positively by investors as they can enhance earnings per share and demonstrate capital allocation discipline. The consistent execution of the program (8.56 million shares repurchased year-to-date) indicates strong financial performance and cash generation capability.

#share buyback #treasury shares #capital reduction #share repurchase program #shareholder returns

GlobeNewswire Inc. • Na

Director/PDMR Shareholding

12/31/2025 04:00 AM • Vanessa Vilar, Chief Legal Officer of The Magnum Ice Cream Company N.V., has acquired 7,491 ordinary shares valued at €100,004.85 on December 30, 2025, at a price of €13.35 per share on the Amsterdam Stock Exchange. The transaction is disclosed in accordance with EU and UK Market Abuse Regulation 596/2014.

BACpP - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
MICC - The insider share purchase by a senior executive (CLO) is a routine regulatory disclosure. While insider buying can sometimes signal confidence in the company, this single transaction lacks sufficient context regarding market conditions, company performance, or strategic significance to warrant a positive or negative sentiment. The disclosure is purely informational and compliant with regulatory requirements.

#PDMR transaction #share acquisition #Chief Legal Officer #insider trading disclosure #Amsterdam Stock Exchange #Market Abuse Regulation

Investing Legend Warren Buffett Bids Adieu to Wall Street, While His Trillion-Dollar Company, Berkshire Hathaway, Enters a New Era

The Motley Fool • Sean Williams

Investing Legend Warren Buffett Bids Adieu to Wall Street, While His Trillion-Dollar Company, Berkshire Hathaway, Enters a New Era

12/31/2025 03:36 AM • Warren Buffett steps down as CEO of Berkshire Hathaway on December 31, 2025, after 60+ years, with Greg Abel taking over. Despite being a net seller of stocks for 12 quarters, Buffett's value-focused philosophy and long-term approach nearly doubled S&P 500 returns. Abel is expected to continue this strategy while potentially expanding into technology and healthcare sectors, though some core holdings like Apple may be reconsidered.

BACpS - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
BRK.A - Strong legacy of 6,060,000% cumulative return on Class A shares over 60+ years. Transition to Abel is expected to be seamless with continued value-focused philosophy and similar investment approach. Company maintains trillion-dollar valuation with solid foundation.

#Warren Buffett retirement #Greg Abel CEO #Berkshire Hathaway transition #value investing #long-term investing philosophy #stock portfolio management #corporate leadership change

OBOOK Holdings Inc. (OWLS) Announces Commencement of $10 Million Share Repurchase Program

GlobeNewswire Inc. • Obook Holdings Inc.

OBOOK Holdings Inc. (OWLS) Announces Commencement of $10 Million Share Repurchase Program

12/31/2025 02:53 AM • OBOOK Holdings Inc. (NASDAQ: OWLS), a blockchain technology company, announced it has entered the execution phase of a $10 million share repurchase program. The company, which operates the OwlTing Group with a focus on card payment and stablecoin settlement infrastructure, is implementing the program to optimize capital structure and enhance shareholder value while maintaining strong operating cash flow for global expansion.

BACpO - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
OWLS - The company is demonstrating financial confidence through a $10 million share repurchase program while maintaining strong operating cash flow for growth. Management's statements reflect optimism about fundamentals and strategic direction, with advancement in core infrastructure and enterprise activation initiatives. The ability to balance growth investments with capital optimization suggests solid financial health.

#share repurchase #blockchain technology #stablecoin #capital allocation #shareholder value #OwlPay #payment infrastructure

CCH Holdings Ltd Announces Full Exercise of Over-Allotment Option

GlobeNewswire Inc. • Not Specified

CCH Holdings Ltd Announces Full Exercise of Over-Allotment Option

12/31/2025 01:31 AM • CCH Holdings Ltd, a Malaysia-based specialty hotpot restaurant chain, announced that underwriters fully exercised their over-allotment option on December 31, 2025, purchasing an additional 187,500 shares at US$4.00 per share. This increased total IPO proceeds to US$5.75 million from the original US$5.0 million. The company's shares began trading on Nasdaq Capital Market under ticker 'CCHH' on October 3, 2025.

BACpN - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
CCHH - The company successfully completed its IPO with full exercise of the over-allotment option, indicating strong investor demand. The additional share purchase increased gross proceeds by US$750,000, demonstrating confidence from underwriters and market participants in the company's prospects as a leading specialty hotpot restaurant chain in Malaysia.

#IPO #over-allotment option #hotpot restaurant #Malaysia #Nasdaq Capital Market #initial public offering #underwriters

Micron Gains Momentum, Again—30% to 80% Upside in 2026

Investing.com • Thomas Hughes

Micron Gains Momentum, Again—30% to 80% Upside in 2026

12/31/2025 12:44 AM • Micron (MU) stock has broken out to new highs in December 2025, with technical analysis suggesting 30% to 80% upside potential by mid-2026. The rally is driven by strong Q1 FY2026 earnings results and analyst sentiment, supported by an unprecedented HBM memory shortage tied to AI and data center demand. The stock trades at a deep valuation discount relative to tech peers, with 37 analysts maintaining a consensus Buy rating and increasing price targets.

BACpL - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
MU - Strong earnings results, technical breakout to new highs, consensus Buy rating from 37 analysts with increasing price targets, unprecedented HBM memory shortage supporting pricing power, and deep valuation discount relative to peers all support positive outlook with 30-80% upside potential through mid-2026.

#Micron #HBM memory shortage #AI demand #data centers #technical breakout #analyst upgrades #GPU demand #valuation discount

Why 2026 Could Be Another Breakout Year for Rocket Lab

Investing.com • Ryan Hasson

Why 2026 Could Be Another Breakout Year for Rocket Lab

12/31/2025 12:40 AM • Rocket Lab (RKLB) has surged 1,775% over three years and 175% year-to-date, yet analysts believe significant growth catalysts remain ahead. Key drivers include the upcoming Neutron medium-lift rocket launch, a record $816 million Space Development Agency contract for 18 satellites, perfect 100% mission success rate in 2025 with 21 Electron launches, and potential sector tailwinds from a speculated SpaceX IPO in mid-2026. Wall Street analysts have raised price targets, with consensus at $61.25 and Moderate Buy ratings.

BACpM - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
RKLB - Company demonstrates exceptional execution with 100% mission success rate in 2025, secured largest contract in its history ($816M), approaching critical Neutron inflection point, expanding defense contractor role, and positioned to benefit from sector-wide tailwinds. Multiple analyst price target increases and strong retail investor enthusiasm support positive outlook for 2026.

#Rocket Lab #Neutron rocket #space launch #defense contracts #satellite deployment #SpaceX IPO #aerospace and defense #small-lift orbital rocket

Why Did Oriental Rise Holdings (ORIS) Shares Surge Over 47% After Hours?

Benzinga • Mohd Haider

Why Did Oriental Rise Holdings (ORIS) Shares Surge Over 47% After Hours?

12/30/2025 11:42 PM • Oriental Rise Holdings (NASDAQ: ORIS) shares surged 47.54% to $1.80 in after-hours trading following the announcement of a non-binding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group Co. Ltd. The acquisition aims to secure upstream resources and improve supply chain control, product differentiation, and long-term shareholder value. However, the stock remains near its 52-week low and has declined 95.7% over the past 12 months.

BACpK - The announcement indicates a strategic increase in financial instruments without explicit positive or negative implications, representing a neutral market movement
ORIS - The company announced a strategic acquisition of a controlling stake in a major tea producer, which drove a 47.54% after-hours surge. The deal aligns with long-term strategic objectives to improve supply chain control and competitiveness. However, the positive sentiment is tempered by the stock's severe long-term weakness (95.7% decline over 12 months) and its proximity to 52-week lows, suggesting underlying fundamental challenges.

#acquisition #tea industry #supply chain #strategic investment #after-hours trading #vertically integrated operations

Michael Burry Says Tesla Is 'Ridiculously Overvalued' After Earlier Warning About The Elon 'Cult'

Benzinga • Vishaal Sanjay

Michael Burry Says Tesla Is 'Ridiculously Overvalued' After Earlier Warning About The Elon 'Cult'

12/30/2025 10:55 PM • Investor Michael Burry criticized Tesla as 'ridiculously overvalued,' citing decelerating sales momentum and a P/E ratio of 204x compared to the industry average of 17.47x. Tesla's Q4 consensus estimates came in 14.93% below the prior quarter and 15% below year-over-year. Burry also warned about Elon Musk's trillion-dollar pay package causing 3.6% annual shareholder dilution. Tesla remains the world's most valuable automaker with a $1.53 trillion market cap despite facing its second consecutive annual sales decline.

BMLpH - The announcement indicates a significant increase in shareholding, which suggests strategic interest but without explicit positive or negative implications
TSLA - Michael Burry, a renowned investor who correctly predicted the 2008 financial crisis, explicitly called Tesla 'ridiculously overvalued.' The company trades at 204x forward earnings versus industry average of 17.47x, faces declining sales momentum (Q4 down 14.93% QoQ and 15% YoY), and is headed for its second consecutive annual sales decline. Additionally, concerns about shareholder dilution from Elon Musk's compensation package and competitive pressures in autonomous vehicles and robotics further support the negative outlook.

#Tesla valuation #Michael Burry #vehicle sales decline #P/E ratio #Elon Musk compensation #shareholder dilution #Q4 deliveries #autonomous driving #electric vehicles

DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

GlobeNewswire Inc. • Kahn Swick & Foti, Llc

DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/30/2025 10:53 PM • Kahn Swick & Foti, LLC announces a class action securities lawsuit against DeFi Technologies Inc. for alleged securities fraud between May 12 and November 14, 2025. The company disclosed a nearly 20% revenue decline and slashed its 2025 revenue forecast from $218.6 million to $116.6 million, citing delays in executing DeFi Alpha arbitrage opportunities. The stock price fell 27.59% following the announcement. Investors have until January 30, 2026 to request lead plaintiff status.

BMLpJ - The announcement indicates a significant increase in shareholding, which suggests strategic interest but without explicit positive or negative implications
DEFT - The company faces a class action lawsuit for alleged securities fraud, disclosed a nearly 20% revenue decline, significantly lowered its 2025 revenue forecast by approximately 47% ($218.6M to $116.6M), and experienced a 27.59% stock price decline following the announcement.

#class action lawsuit #securities fraud #revenue decline #stock price decline #DeFi Technologies #financial results #lead plaintiff deadline

Peter Schiff Says Silver Investors Are In 'Denial' As Mining Stocks Continue To Lag: 'Should Have Doubled' In December

Benzinga • Vishaal Sanjay

Peter Schiff Says Silver Investors Are In 'Denial' As Mining Stocks Continue To Lag: 'Should Have Doubled' In December

12/30/2025 10:48 PM • Economist Peter Schiff criticizes the disconnect between silver's 35% December surge and silver mining stocks' modest 11% gain, arguing mining stocks should have doubled given their typical leveraged exposure to the metal. Despite silver's historic rally and 154.57% year-to-date gains, major mining stocks and ETFs have significantly underperformed, presenting what Schiff views as an attractive buying opportunity.

BMLpL - The announcement indicates a significant increase in shareholding, which suggests strategic interest but without explicit positive or negative implications
AG - Stock up only 6.76% in December despite silver surging 35%; significantly underperformed relative to the underlying commodity's rally

#silver prices #mining stocks #underperformance #leveraged exposure #Peter Schiff #precious metals #market disconnect

Alexandria Real Estate Equities Securities Fraud Class Action Result of Financial Issues and Approximately 19% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire Inc. • Kahn Swick & Foti, Llc

Alexandria Real Estate Equities Securities Fraud Class Action Result of Financial Issues and Approximately 19% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/30/2025 10:42 PM • Alexandria Real Estate Equities faces a securities class action lawsuit for allegedly failing to disclose material information. The company disclosed disappointing Q3 2025 results on October 27, 2025, including a $323.9 million real estate impairment charge and FFO guidance cuts due to lower occupancy and slower leasing. The stock declined approximately 19% in a single day. Investors have until January 26, 2026 to file lead plaintiff applications.

MERpK - The announcement indicates a significant increase in shareholding, which suggests strategic interest but without explicit positive or negative implications
ARE - The company faces securities fraud allegations for failing to disclose material information, reported disappointing Q3 results with a $323.9 million impairment charge, cut full-year FFO guidance, and experienced a sharp 19% single-day stock decline from $77.87 to $62.94 per share due to lower occupancy rates and slower leasing activity.

#securities fraud #class action lawsuit #financial disclosure #real estate impairment #stock decline #FFO guidance #occupancy rates